Plasminogen Activators Potentiate Thrombin-Induced Brain Injury
Author(s) -
Bryan E. Figueroa,
Richard F. Keep,
A. Lorris Betz,
Julian T. Hoff
Publication year - 1998
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/01.str.29.6.1202
Subject(s) - medicine , thrombin , intracerebral hemorrhage , tissue plasminogen activator , pharmacology , urokinase , fibrinolysis , brain edema , edema , context (archaeology) , anesthesia , platelet , subarachnoid hemorrhage , biology , paleontology
Evidence suggests that cerebral edema following intracerebral hemorrhage (i.c.h.) results from a mass effect in combination with neurotoxic injury from clot-derived substrates such as thrombin. Thrombolytics can compete for thrombin inhibitors endogenous to the brain. This study examines the effect of intracerebral infusion of thrombolytics, tissue plasminogen activator (tPA), and urokinase (uPA), individually and in combination with thrombin.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom